Articles Tagged With:
-
Initial Orthostatic Hypotension: An Under-Recognized Form of Orthostatic Hypotension
Initial orthostatic hypotension represents a population at risk for falls, which may be missed with traditional methods of orthostatic BP measurement.
-
Delay in Diagnosis of Hepatocellular Carcinoma
Diagnostic delays are common among patients with hepatocellular carcinoma. -
A Glimmer of Hope for Beta-Blockers in Heart Failure from Diastolic Dysfunction
Because these data are observational in nature, they cannot definitively establish whether beta-blocker treatment reduces mortality in d-CHF, but they provide strong impetus to perform a large randomized trial to ultimately answer the question. -
Left Atrial Appendage Closure: Another Possible Interventional Fix for Atrial Fibrillation
Left atrial appendage closure may be another reasonable option for reduction of stroke risk in atrial fibrillation. -
Can You Make ‘Flat’ Basal Insulin ‘Flatter?’
For patients incurring problematic episodes of hypoglycemia, an insulin that provides even “flatter” plasma levels may provide an advantage.
-
FDA Actions
The FDA has approved two drugs for the treatment of diarrhea-predominant irritable bowel syndrome.
-
Addition of Ezetimibe to Simvastatin May Improve CV Outcomes
A new study suggests the addition of ezetimibe to simvastatin may improve cardiovascular outcomes in patients with acute coronary syndrome, although the effect is modest.
-
Beta-blockade Use in Non-cardiac Surgery Patients
Perioperative beta-blockade appears to be beneficial for patients with high cardiac risk factors undergoing NCS, but it increased the risk of death in those with no cardiac risk factors.
-
Compliance Mentor - June 2015
-
Spring clean IRB reviews by focusing on review criteria
As IRB workloads shift to summer schedules, it’s a good time to assess whether boards are staying on mission focus, an IRB chair suggests.